Investors in PMI can take the lead in Picard Medical, Inc. securities fraud lawsuit

Investors who have put their money into Picard Medical, Inc. (NYSE American: PMI) have the opportunity to take the lead in a securities fraud lawsuit according to The Rosen Law Firm, P.A. This class action lawsuit pertains to purchases of PMI securities between September 2, 2025, and October 31, 2025. The deadline for investors to become the lead plaintiff in this case is April 13, 2026.

During the mentioned Class Period, investors who bought Picard Medical securities may be eligible for compensation. There will be no need for them to pay any fees or costs out of pocket due to a contingency fee arrangement. To get involved in the Picard Medical class action, investors should visit the website provided or get in touch with Phillip Kim, Esq. either by phone or email. Acting as a lead plaintiff means representing other members of the class in legal proceedings.

The Rosen Law Firm emphasizes the importance of choosing a qualified legal representative with a proven track record of successful leadership in similar cases. The firm asserts that many organizations issuing legal notices lack the necessary experience, resources, and recognition in this area. The Rosen Law Firm specializes in representing investors worldwide, particularly in securities class actions and shareholder derivative litigation. Notably, the firm has secured the largest securities class action settlement against a Chinese company up to that point in time.

Investors need to act promptly if they wish to serve as the lead plaintiff in the Picard Medical securities fraud lawsuit. The deadline for taking on this role is April 13, 2026. By participating in this legal action, investors can potentially secure compensation for their losses without incurring any financial burden upfront.

The opportunity to lead the Picard Medical, Inc. securities fraud lawsuit is a chance for investors to assert their rights and seek justice for any alleged wrongdoing. The Rosen Law Firm is equipped to support investors globally in navigating complex legal matters related to securities fraud, ensuring that their interests are represented effectively in court.

Investors who believe they have been affected by the securities fraud involving Picard Medical, Inc. should take action promptly to safeguard their rights and potentially recover any losses they may have suffered during the specified Class Period. The Rosen Law Firm stands ready to assist investors in pursuing claims against those responsible for any alleged misconduct.